Skip to content
Back

Elisabeth Mayr, PhD

Management Research and Clinical Research

Research statement

My main scientific interest is translating research from bench to bedside. After my postdoc in the gene therapy group I decided to switch to an administrative position where I am responsible for research management und clinical trials and can facilitate translation of research results into the clinic.

Curriculum Vitae Elisabeth Mayr

Professional Career

Since 2015
Management Research and Clinical Research, EB House Austria

2013-2014
Research Coordination, EB House Austria

2011-2013
Postdoc, EB House Austria

 

Education

2011
PhD, Paris Lodron University Salzburg
"5´ Trans-splicing in the type VII collagen gene: Development of an mRNA based gene therapy approach for dystrophic epidermolysis bullosa"
Research group: Prof. Dr. Johann Bauer (EB House Austria)

2007
MSc in Genetics and Biotechnology, Paris Lodron University Salzburg
"Etablierung der Zinkfingernuclease-Technologie zur Induktion der humanen endogenen Laminin-beta3 Mutation R635X in HaCaT Zellkultur"
Research group: Prof. Dr. Johann Bauer (EB House Austria)

2005
BSc in Genetics and Molecular Biology, Paris Lodron University Salzburg

 

Awards and Fellowships

2011 Scientific award in bronze from the Paracelsus Medical University, Salzburg

 

Additional qualifications/training

2018 GCP Certificate
2017 Organization of Scientific Congresses; Seminar, Mannheim, Germany
2017 Intellectuel Property in H2020 projects; Seminar, Salzburg
2016 ISO 9001:2015; Seminar, Salzburg
2016 Data Protection and Professional Discretion; Seminar, Salzburg
2016 Clinical Studies, Masterclass; Salzburg
2015 Project Development and Submission in Horizon-2020; Seminar, Vienna
2015 Study Protocols, Seminar, Salzburg
2014 Clinical Studies: Submission to Ethics Committee and regualtory Authorities; Seminar, Salzburg
2014 Science Communication; Seminar, Vienna
2013 Certified Quality Representative and Certified Quality Auditor in Health Care since

Original articles

  1. Bauer JW, Koller J, Murauer EM, De RL, Enzo E, Carulli S, Bondanza S, Recchia A, Muss W, Diem A, Mayr E, Schlager P, Gratz IK, Pellegrini G, De LM. Closure of a large chronic wound through transplantation of gene-corrected epidermal stem cells. J Invest Dermatol 2016.
  2. Peking P, Koller U, Hainzl S, Kitzmueller S, Kocher T, Mayr E, Nystrom A, Lener T, Reichelt J, Bauer JW, Murauer EM. A Gene Gun-mediated Nonviral RNA trans-splicing Strategy for Col7a1 Repair. Mol Ther Nucleic Acids 2016;5:e287.
  3. Koller U, Hainzl S, Kocher T, Huttner C, Klausegger A, Gruber C, Mayr E, Wally V, Bauer JW, Murauer EM. Trans-splicing improvement by the combined application of antisense strategies. Int J Mol Sci 2015;16:1179-91.
  4. Koller U, Wally V, Mitchell LG, Klausegger A, Murauer EM, Mayr E, Gruber C, Hainzl S, Hintner H, Bauer JW. A novel screening system improves genetic correction by internal exon replacement. Nucleic Acids Res 2011;39:e108.
  5. Gruber C, Gratz IK, Murauer EM, Mayr E, Koller U, Bruckner-Tuderman L, Meneguzzi G, Hintner H, Bauer JW. Spliceosome-mediated RNA trans-splicing facilitates targeted delivery of suicide genes to cancer cells. Mol Cancer Ther 2011;10:233-41.

Book chapters

  1. Mayr E, Koller U, Bauer JW. (2013). Gene Therapy for the COL7A1 Gene. Gene Therapy - Tools and Potential Applications, ISBN: 978-953-51-1014-9.
Back to main navigation